Related Experiment Video
Updated: Oct 4, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells
Yongmei Jin1, Lingli Xu2, Bin Zhao2
1Department of Nursing, Shanghai Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Abstract:
This study aimed to explore the role and potential mechanism of the long non-coding (lncRNA) MBNL1-AS1 in human breast cancer. We included 80 patients with breast cancer in this study. Breast cancer cell lines, including MCF7, SKBR3, MDA-MB-231 and MDA-MB-415, and the normal human breast cell line MCF10A were used in this study. MBNL1-AS1, miR-889-3p mimics, si-Krüppel-like factor 9 (KLF9) or their controls were transfected in the cells. Quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blotting and immunohistochemistry assay were performed to detect the expression of MBNL1-AS1, miR-889-3p and KLF9. Cell proliferation, invasion and migration were detected. Luciferase reporter gene and pull-down assay were performed to verify the target relationship among MBNL1-AS1, miR-889-3p and KLF9. Glycolysis was also detected after transfection. The expression of the lncRNA MBNL1-AS1 was low in the breast cancer tissues and cells. Lower expression levels of the lncRNA MBNL1-AS1 were associated with poor prognosis of breast cancer. Overexpression of the lncRNA MBNL1-AS1 decreased proliferation, invasion, migration and glycolysis of breast cancer cells. The lncRNA MBNL1-AS1 could interact with miR-889-3p, and KLF9 was the downstream target of miR-889-3p. Moreover, miR-889-3p was negatively correlated with KLF9 and lncRNA MBNL1-AS1. Both miR-889-3p and si-KLF9 could reverse the overexpression of lncRNA MBNL1-AS1 in breast cancer development. The lncRNA MBNL1-AS1 decreased proliferation, invasion, migration and glycolysis of breast cancer via the miR-889-3p/KLF9 axis, which might be a potential biomarker for the diagnosis of breast cancer.
Insights
The long non-coding RNA MBNL1-AS1 suppresses breast cancer progression by inhibiting cell proliferation, invasion, migration, and glycolysis. MBNL1-AS1 acts via the miR-889-3p/KLF9 pathway, suggesting its potential as a diagnostic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading cause of mortality in women worldwide.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
- The specific function of MBNL1-AS1 in breast cancer remains largely unexplored.
Purpose of the Study:
- To investigate the role and underlying mechanism of lncRNA MBNL1-AS1 in human breast cancer.
- To determine the relationship between MBNL1-AS1 expression and clinical prognosis.
- To elucidate the molecular interactions involving MBNL1-AS1, miR-889-3p, and KLF9.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting to assess gene and protein expression.
- Cell-based assays to evaluate proliferation, invasion, migration, and glycolysis.
- Luciferase reporter and pull-down assays to confirm molecular interactions.
- Transfection of MBNL1-AS1, miR-889-3p mimics, and si-KLF9 in breast cancer cell lines.
Main Results:
- MBNL1-AS1 expression was significantly downregulated in breast cancer tissues and cell lines.
- Low MBNL1-AS1 levels correlated with poor patient prognosis.
- Overexpression of MBNL1-AS1 inhibited breast cancer cell proliferation, invasion, migration, and glycolysis.
- MBNL1-AS1 directly targets miR-889-3p, which in turn targets KLF9, forming an inhibitory axis.
Conclusions:
- lncRNA MBNL1-AS1 functions as a tumor suppressor in breast cancer.
- The MBNL1-AS1/miR-889-3p/KLF9 axis plays a critical role in regulating breast cancer cell behaviors.
- MBNL1-AS1 holds potential as a diagnostic biomarker and therapeutic target for breast cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

